back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-11-13 Tx date 2017-11-09 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Sievers, Eric L
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$342,758
+28,049 vol $12.22 each |
191,386 | |
| Filed 2017-08-31 Tx date 2017-08-28 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Sievers, Eric L
5 - Senior Officer of Issuer
Holder: Eric and Nicole Sievers (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,173
+10,640 vol $4.62 each |
52,884 | |
| Filed 2016-12-14 Tx date 2016-12-12 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Sievers, Eric L
5 - Senior Officer of Issuer
Holder: Eric and Nicole Sievers (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$62,305
+10,000 vol $6.23 each |
42,244 | |
| Filed 2016-11-10 Tx date 2016-11-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Sievers, Eric L
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,381
+20,911 vol $9.20 each |
163,337 | |
| Filed 2016-05-30 Tx date 2016-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Sievers, Eric L
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+28,713 vol |
142,426 | |
| Filed 2016-05-19 Tx date 2016-05-18 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Sievers, Eric L
5 - Senior Officer of Issuer
Holder: Eric and Nicole Sievers (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,988
+9,224 vol $10.84 each |
32,244 | |
| Filed 2016-03-22 Tx date 2016-03-21 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Sievers, Eric L
5 - Senior Officer of Issuer
Holder: Eric and Nicole Sievers (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$188,994
+23,020 vol $8.21 each |
23,020 | |
| Filed 2016-03-22 Tx date 2015-04-01 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Sievers, Eric L
5 - Senior Officer of Issuer
Holder: Eric and Nicole Sievers (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-11-20 Tx date 2015-11-19 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Sievers, Eric L
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+28,713 vol |
113,713 |